Isoliquiritigenin is a Novel NMDA Receptor Antagonist in Kampo Medicine Yokukansan

Suppression of ROS generation by 4,4'-diaminodiphenylsulfone in non-phagocytic human diploid fibroblasts

(2010) Sung Chun Cho et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Yokukansan, a kampo medicine, protects against glutamate cytotoxicity due to oxidative stress in PC12 cells

(2010) Zenji Kawakami et al.   JOURNAL OF ETHNOPHARMACOLOGY

Effects of Yokukansan, a Traditional Japanese Medicine, on Memory Disturbance and Behavioral and Psychological Symptoms of Dementia in Thiamine-Deficient Rats

(2009) Yasushi Ikarashi et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Glycyrrhizin and its metabolite 18β-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes

(2009) Zenji Kawakami et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Neuroprotective effects of yokukansan, a traditional japanese medicine, on glutamate-mediated excitotoxicity in cultured cells

(2009) Z. Kawakami et al.   NEUROSCIENCE

A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia

(2008) Katsuyoshi Mizukami et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease

(2008) Akira Monji et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY